halothane has been researched along with Chronic Insomnia in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Torsade de pointes (TdP) occurred in a long QT syndrome type 3 (LQT3) patient after switching perospirone to blonanserin." | 3.96 | Experimental analysis of the onset mechanism of TdP reported in an LQT3 patient during pharmacological treatment with serotonin-dopamine antagonists against insomnia and nocturnal delirium. ( Chiba, K; Goto, A; Hagiwara-Nagasawa, M; Izumi-Nakaseko, H; Kambayashi, R; Matsumoto, A; Naito, AT; Sugiyama, A, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kambayashi, R | 1 |
| Hagiwara-Nagasawa, M | 1 |
| Goto, A | 1 |
| Chiba, K | 1 |
| Izumi-Nakaseko, H | 1 |
| Naito, AT | 1 |
| Matsumoto, A | 1 |
| Sugiyama, A | 1 |
1 other study available for halothane and Chronic Insomnia
| Article | Year |
|---|---|
Experimental analysis of the onset mechanism of TdP reported in an LQT3 patient during pharmacological treatment with serotonin-dopamine antagonists against insomnia and nocturnal delirium.
Topics: Action Potentials; Anesthetics, Inhalation; Animals; Calcium Channel Agonists; Cardiac Conduction Sy | 2020 |